Watch for Adbry, Cibinqo, and Rinvoq for Eczema

More meds for moderate to severe atopic dermatitis will try to squeeze into the market...Adbry, Cibinqo, and Rinvoq.

Save these specialty meds for when topicals (steroids, etc) aren’t enough. Include these in the EHR, even if you’re not prescribing them.

Adbry (tralokinumab) is similar to Dupixent (dupilumab). Both are injectable monoclonal antibodies that reduce inflammation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote